Menys Valentine C, Liu Yifen, Mackness Michael I, Caslake Muriel J, Kwok See, Durrington Paul N
Department of Medicine, Manchester Royal Infirmary, Oxford Road, M13 9WL, Manchester, UK.
Clin Chim Acta. 2003 Aug;334(1-2):95-106. doi: 10.1016/s0009-8981(03)00231-6.
Existing methods for detecting small-dense low-density lipoprotein (SD-LDL) are either semiquantitative (e.g., gradient gel electrophoresis) or require specialised laboratory methods (e.g., density-gradient ultracentrifugation, DGU).
We report a method in which plasma was adjusted to a density (D) of 1.044 and 1.060 g/ml, respectively, in two tubes, both of which underwent ultracentrifugation (UC). A measure of SD-LDL apolipoprotein B (apo B) was obtained by subtraction of the apo B concentration in D>1.060 g/ml lipoproteins from that in D>1.044 g/ml lipoproteins to correct for apo B associated with lipoprotein (a) [Lp(a)]. This procedure was evaluated in paired plasma samples in healthy men (n=62) and in age-matched healthy women (n=74) and in age-matched primary dyslipidaemic men (n=72) and women (n=29) and compared with an established density-gradient ultracentrifugation (DGU) method.
The dyslipidaemic patients had either decreased high-density lipoprotein cholesterol (HDL-C) and/or increased triglycerides. In dyslipidaemic men, SD-LDL apo B level (23 [5-77] mg/dl) was significantly higher than in healthy men (P<0.001). In dyslipidaemic women, the SD-LDL apo B levels (11 [4-71] mg/dl) were significantly higher than in healthy women (7 [1-45] mg/dl; P<0.005). The concentration of SD-LDL apo B correlated inversely with HDL-C in both women (r=-0.280: P<0.005) and men (r=-0.464; P<0.0001) and positively with triglyceride concentration in both women (r=0.213; P<0.05) and men (r=0.592: P<0.0001). Correction for apo B in Lp(a) increased the analytical variation, which was 12% for apo B at D=1.044-1.060 g/ml and 9% for apo B measured at D>1.044 g/ml. Although the correlation between the new method and DGU results was high (r=0.830; P<0.0001, n=43), the concentration of apo B at D>1.044 g/ml correlated strongly with both corrected results (r=0.978; P<0.0001; n=237) and also with SD-LDL isolated using the DGU method (r=0.832; P<0.0001). Results at D>1.044 g/ml showed the expected correlations both with HDL-C (r=-0.465: P<0.0001) and triglycerides (r=0.526; P<0.0001).
The new method gave results consistent with earlier published findings using other techniques. Further simplification of the method using a single-density spin at D>1.044 g/ml appears feasible and may provide an easier quantitative method for clinical use.
现有的检测小而密低密度脂蛋白(SD-LDL)的方法要么是半定量的(如梯度凝胶电泳),要么需要专门的实验室方法(如密度梯度超速离心,DGU)。
我们报告了一种方法,将血浆分别在两个试管中调整至密度(D)为1.044和1.060 g/ml,然后都进行超速离心(UC)。通过从D>1.044 g/ml脂蛋白中的载脂蛋白B(apo B)浓度减去D>1.060 g/ml脂蛋白中的apo B浓度来获得SD-LDL apo B的测量值,以校正与脂蛋白(a)[Lp(a)]相关的apo B。该程序在健康男性(n = 62)和年龄匹配的健康女性(n = 74)以及年龄匹配的原发性血脂异常男性(n = 72)和女性(n = 29)的配对血浆样本中进行评估,并与既定的密度梯度超速离心(DGU)方法进行比较。
血脂异常患者的高密度脂蛋白胆固醇(HDL-C)降低和/或甘油三酯升高。在血脂异常男性中,SD-LDL apo B水平(23 [5 - 77] mg/dl)显著高于健康男性(P < 0.001)。在血脂异常女性中,SD-LDL apo B水平(11 [4 - 71] mg/dl)显著高于健康女性(7 [1 - -45] mg/dl;P < 0.005)。SD-LDL apo B的浓度在女性(r = -0.280;P < 0.005)和男性(r = -0.464;P < 0.0001)中均与HDL-C呈负相关,在女性(r = 0.213;P < 0.05)和男性(r = 0.592;P < 0.0001)中均与甘油三酯浓度呈正相关。校正Lp(a)中的apo B会增加分析变异,对于D = 1.044 - 1.060 g/ml时的apo B,变异为12%,对于D>1.044 g/ml时测量的apo B,变异为9%。尽管新方法与DGU结果之间的相关性很高(r =
0.830;P < 0.0001,n = 43),但D>1.044 g/ml时的apo B浓度与校正结果(r = 0.978;P < 0.0001;n = 237)以及使用DGU方法分离的SD-LDL均密切相关(r = 0.832;P < 0.0001)。D>1.044 g/ml时的结果与HDL-C(r = -0.465;P < 0.0001)和甘油三酯(r = 0.526;P < 0.0001)均呈现预期的相关性。
新方法得到的结果与使用其他技术早期发表的结果一致。使用D>1.044 g/ml的单密度离心对该方法进行进一步简化似乎可行,并且可能为临床应用提供一种更简便的定量方法。